Rob Hegele

Rob Hegele

Western University

H-index: 131

North America-Canada

About Rob Hegele

Rob Hegele, With an exceptional h-index of 131 and a recent h-index of 77 (since 2020), a distinguished researcher at Western University, specializes in the field of lipids, genetics, atherosclerosis, diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Lipoprotein (a) in Familial Hypercholesterolemia

Consideration and Application of Lipoprotein (a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults

Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia

A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME

Inhibiting angiopoietin-like protein 3: clear skies or clouds on the horizon?

Recommendations for statin management in primary prevention: disparities among international risk scores

Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Rob Hegele Information

University

Western University

Position

Robarts Research Institute

Citations(all)

79893

Citations(since 2020)

32483

Cited By

60104

hIndex(all)

131

hIndex(since 2020)

77

i10Index(all)

709

i10Index(since 2020)

436

Email

University Profile Page

Western University

Rob Hegele Skills & Research Interests

lipids

genetics

atherosclerosis

diabetes

Top articles of Rob Hegele

Title

Journal

Author(s)

Publication Date

Lipoprotein (a) in Familial Hypercholesterolemia

CJC open

Erin O Jacob

Adam D McIntyre

Jian Wang

Robert A Hegele

2024/1/1

Consideration and Application of Lipoprotein (a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults

Tiffany Yuen

GB John Mancini

Robert A Hegele

Glen J Pearson

2023/11/18

Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia

Journal of the American Heart Association

Natalia Ryzhaya

Lubomira Cermakova

Mark Trinder

Isabelle Ruel

Thais Coutinho

...

2021/6/1

A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME

Journal of the American College of Cardiology

Erik SG Stroes

Vickie Alexander

Ewa Prokopczuk

Robert Hegele

Marcello Arca

...

2024/4/2

Inhibiting angiopoietin-like protein 3: clear skies or clouds on the horizon?

Robert A Hegele

2024/2/16

Recommendations for statin management in primary prevention: disparities among international risk scores

European Heart Journal

GB John Mancini

Arnold Ryomoto

Eunice Yeoh

Liam R Brunham

Robert A Hegele

2024/1/7

Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study

Alzheimer's & Dementia

Ryota Sakurai

Frederico Pieruccini‐Faria

Benjamin Cornish

Julia Fraser

Malcolm A Binns

...

2024/4

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

JAMA cardiology

Janneke WCM Mulder

Tycho R Tromp

Mutaz Al-Khnifsawi

Dirk J Blom

Krysztof Chlebus

...

2024/2/14

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

The Lancet

Kanika Inamdar Dharmayat

Antonio J Vallejo-Vaz

Christophe AT Stevens

Julia M Brandts

Alexander RM Lyons

...

2024/1/6

Genetic variation in apolipoprotein AV in hypertriglyceridemia

Shehan D Perera

Robert A Hegele

2023/12/21

Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies

Arteriosclerosis, Thrombosis, and Vascular Biology

Frederick J Raal

Robert A Hegele

Andrea Ruzza

J Antonio G López

Ajay K Bhatia

...

2024/5

A Century of Milestones and Breakthroughs Related to Low-and High-Density Lipoproteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Mary G Sorci-Thomas

Robert A Hegele

Alan T Remaley

2024/1

Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia

The New England journal of medicine

Veronica J Alexander

Ewa Karwatowska-Prokopczuk

Thomas A Prohaska

Lu Li

Richard S Geary

...

2024/2/1

Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome

Atherosclerosis

Amanda J Berberich

Robert A Hegele

2024/3/26

Carotid intima medial thickness in patients with severe hypertriglyceridemia

Atherosclerosis Plus

Maud Ahmad

Brooke A Kennedy

Surim Son

Adam D McIntyre

Julieta Lazarte

...

2024/4/21

New clarity for managing statin intolerance in diabetes

The Lancet Diabetes & Endocrinology

Robert A Hegele

2024/1/1

Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Martine Paquette

Bertrand Cariou

Sophie Bernard

Robert A Hegele

Antonio Gallo

...

2024/2

Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative …

Alzheimer's & Dementia

Erlan Sanchez

Tim Wilkinson

Gillian Coughlan

Saira Mirza

Andrée‐Ann Baril

...

2024/3

Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome

The New England Journal of Medicine

Erik SG Stroes

Veronica J Alexander

Ewa Karwatowska-Prokopczuk

Robert A Hegele

Marcello Arca

...

2024/4/7

Association of plasma biomarkers with cognitive domains across three neurodegenerative diseases and cerebrovascular disease

Alzheimer's & Dementia

Erlan Sanchez

Tim Wilkinson

Gillian T Coughlan

Andree‐Ann Baril

Malcolm Binns

...

2023/12

See List of Professors in Rob Hegele University(Western University)

Rob Hegele FAQs

What is Rob Hegele's h-index at Western University?

The h-index of Rob Hegele has been 77 since 2020 and 131 in total.

What are Rob Hegele's top articles?

The articles with the titles of

Lipoprotein (a) in Familial Hypercholesterolemia

Consideration and Application of Lipoprotein (a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults

Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia

A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME

Inhibiting angiopoietin-like protein 3: clear skies or clouds on the horizon?

Recommendations for statin management in primary prevention: disparities among international risk scores

Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

...

are the top articles of Rob Hegele at Western University.

What are Rob Hegele's research interests?

The research interests of Rob Hegele are: lipids, genetics, atherosclerosis, diabetes

What is Rob Hegele's total number of citations?

Rob Hegele has 79,893 citations in total.

What are the co-authors of Rob Hegele?

The co-authors of Rob Hegele are Lawrence Leiter, Thomas MS Wolever, J. David Spence, RUTH MCPHERSON.

Co-Authors

H-index: 146
Lawrence Leiter

Lawrence Leiter

University of Toronto

H-index: 123
Thomas MS Wolever

Thomas MS Wolever

University of Toronto

H-index: 99
J. David Spence

J. David Spence

Western University

H-index: 98
RUTH MCPHERSON

RUTH MCPHERSON

Ottawa University

academic-engine